A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors

Clinical trial NCT06413953 · RECRUITING

Trial details

NCT number: NCT06413953
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2024-06-27
Primary completion: 2026-10-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.